Age-related muscle loss, or sarcopenia, is a growing concern across developed countries, contributing to increased frailty, immobility, and risk of injury among older adults. A study led by researchers at Sanford Burnham Prebys and Stanford University offers insights into one potential approach to reversing these effects by targeting muscle stem cells.
Published on June 12, 2025, in Cell Stem Cell, the research focused on the role of Prostaglandin E2 (PGE2)—a naturally occurring lipid involved in inflammation and healing. In young mice, PGE2 is known to signal muscle stem cells to begin regeneration after injury. However, in aged mice, both PGE2 levels and its receptor (EP4) expression are significantly reduced. This leads to weakened signaling, limiting the cells’ ability to repair muscle.
By administering a stable form of PGE2 to aged mice following muscle injury and exercise, researchers observed improved muscle regeneration and increased strength. The study noted that even a single dose of PGE2 had long-lasting effects, restoring stem cell function and reversing key molecular changes associated with aging.
The findings highlight the broader regenerative potential of PGE2. In addition to influencing muscle stem cells, the molecule may also benefit muscle fibers and neurons and has been implicated in the regenerative processes of other tissues such as the liver and intestine.
The researchers suggest that further exploration of PGE2’s mechanisms could lead to new approaches in managing age-related muscle deterioration and improving overall tissue regeneration.
